Literature DB >> 29150905

Sarcoptic mange in wombats-A review and future research directions.

J M Old1, C Sengupta1, E Narayan1, J Wolfenden1.   

Abstract

Sarcoptic mange is caused by the mite Sarcoptes scabiei and has recently been recognized as an emerging infectious disease of wildlife worldwide. The mite is one of the main causes of population decline in southern hairy-nosed (Lasiorhinus latifrons) and bare-nosed wombats (Vombatus ursinus). This review focuses on Sarcoptes scabiei infestations in wombats and provides insights into why the disease may be so prevalent in wombats. Current treatment practices and trials conducted in the field to reduce the incidence of sarcoptic mange in wombats are described and critically reviewed. Current and potential future avenues of research are discussed.
© 2017 Blackwell Verlag GmbH.

Entities:  

Keywords:  disease; ectoparasite; immune system; one health Sarcoptes scabiei; stress

Mesh:

Year:  2017        PMID: 29150905     DOI: 10.1111/tbed.12770

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  10 in total

Review 1.  Parasites of wombats (family Vombatidae), with a focus on ticks and tick-borne pathogens.

Authors:  Danielle Beard; Hayley J Stannard; Julie M Old
Journal:  Parasitol Res       Date:  2021-01-06       Impact factor: 2.289

2.  The use of Cydectin® by wildlife carers to treat sarcoptic mange in free-ranging bare-nosed wombats (Vombatus ursinus).

Authors:  Julie M Old; Candice J A Skelton; Hayley J Stannard
Journal:  Parasitol Res       Date:  2021-01-13       Impact factor: 2.289

3.  Mapping out bare-nosed wombat (Vombatus ursinus) burrows with the use of a drone.

Authors:  Julie M Old; Simon H Lin; Michael J M Franklin
Journal:  BMC Ecol       Date:  2019-09-18       Impact factor: 2.964

4.  Morphological identification of ticks and molecular detection of tick-borne pathogens from bare-nosed wombats (Vombatus ursinus).

Authors:  Danielle Beard; Hayley J Stannard; Julie M Old
Journal:  Parasit Vectors       Date:  2021-01-19       Impact factor: 3.876

5.  Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use.

Authors:  Vicky Wilkinson; Kotaro Takano; David Nichols; Alynn Martin; Roz Holme; David Phalen; Kate Mounsey; Michael Charleston; Alexandre Kreiss; Ruth Pye; Elizabeth Browne; Christina Næsborg-Nielsen; Shane A Richards; Scott Carver
Journal:  Parasit Vectors       Date:  2021-01-06       Impact factor: 3.876

Review 6.  Pathophysiological and Pharmaceutical Considerations for Enhancing the Control of Sarcoptes scabiei in Wombats Through Improved Transdermal Drug Delivery.

Authors:  Jaskaran Bains; Scott Carver; Susan Hua
Journal:  Front Vet Sci       Date:  2022-06-28

7.  Evidence underscoring immunological and clinical pathological changes associated with Sarcoptes scabiei infection: synthesis and meta-analysis.

Authors:  Christina Næsborg-Nielsen; Vicky Wilkinson; Natalia Mejia-Pacheco; Scott Carver
Journal:  BMC Infect Dis       Date:  2022-07-28       Impact factor: 3.667

8.  Sarcoptic mange changes bacterial and fungal microbiota of bare-nosed wombats (Vombatus ursinus).

Authors:  Christina Næsborg-Nielsen; Raphael Eisenhofer; Tamieka A Fraser; Vicky Wilkinson; Christopher P Burridge; Scott Carver
Journal:  Parasit Vectors       Date:  2022-09-13       Impact factor: 4.047

9.  The cascading pathogenic consequences of Sarcoptes scabiei infection that manifest in host disease.

Authors:  Alynn M Martin; Tamieka A Fraser; John A Lesku; Kellie Simpson; Georgia L Roberts; Jillian Garvey; Adam Polkinghorne; Christopher P Burridge; Scott Carver
Journal:  R Soc Open Sci       Date:  2018-04-18       Impact factor: 2.963

10.  Recent climate-driven ecological change across a continent as perceived through local ecological knowledge.

Authors:  Suzanne M Prober; Nat Raisbeck-Brown; Natasha B Porter; Kristen J Williams; Zoe Leviston; Fiona Dickson
Journal:  PLoS One       Date:  2019-11-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.